| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 8.9e-05 | 1 |